As of 2026-03-20, the EV/EBITDA ratio of OptiBiotix Health PLC (OPTI.L) is -1.91. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. OPTI.L's latest enterprise value is 4.26 mil GBP. OPTI.L's TTM EBITDA according to its financial statements is -2.23 mil GBP. Dividing these 2 quantities gives us the above OPTI.L EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 8.5x - 14.8x | 11.4x |
| Forward P/E multiples | 11.7x - 16.4x | 13.8x |
| Fair Price | (26.00) - (33.22) | (28.16) |
| Upside | -544.5% - -667.9% | -581.3% |
| Date | EV/EBITDA |
| 2026-03-16 | -1.95 |
| 2026-03-13 | -2.11 |
| 2026-03-12 | -2.09 |
| 2026-03-11 | -2.09 |
| 2026-03-10 | -1.88 |
| 2026-03-09 | -1.89 |
| 2026-03-06 | -1.90 |
| 2026-03-05 | -1.87 |
| 2026-03-04 | -1.88 |
| 2026-03-03 | -2.03 |
| 2026-03-02 | -2.10 |
| 2026-02-27 | -2.16 |
| 2026-02-26 | -2.13 |
| 2026-02-25 | -2.13 |
| 2026-02-24 | -2.14 |
| 2026-02-23 | -2.10 |
| 2026-02-20 | -2.11 |
| 2026-02-19 | -2.09 |
| 2026-02-18 | -2.13 |
| 2026-02-17 | -2.14 |
| 2026-02-16 | -1.93 |
| 2026-02-13 | -2.13 |
| 2026-02-12 | -2.30 |
| 2026-02-11 | -2.30 |
| 2026-02-10 | -2.59 |
| 2026-02-09 | -2.70 |
| 2026-02-06 | -2.71 |
| 2026-02-05 | -2.68 |
| 2026-02-04 | -2.69 |
| 2026-02-03 | -2.69 |
| 2026-02-02 | -2.70 |
| 2026-01-30 | -2.54 |
| 2026-01-29 | -2.51 |
| 2026-01-28 | -2.52 |
| 2026-01-27 | -2.74 |
| 2026-01-26 | -3.00 |
| 2026-01-23 | -2.86 |
| 2026-01-22 | -2.83 |
| 2026-01-21 | -2.67 |
| 2026-01-20 | -2.16 |
| 2026-01-19 | -2.16 |
| 2026-01-16 | -2.16 |
| 2026-01-15 | -2.17 |
| 2026-01-14 | -2.18 |
| 2026-01-13 | -2.18 |
| 2026-01-12 | -2.29 |
| 2026-01-09 | -1.96 |
| 2026-01-08 | -2.09 |
| 2026-01-07 | -2.09 |
| 2026-01-06 | -2.10 |